BioTek Instruments, Inc. announces Brad Larson’s promotion to Principal Scientist. Mr. Larson will continue to develop BioTek’s scientific presence in life science and drug discovery markets, and reports to Peter Banks, Scientific Director.
Dr. Banks notes, “Brad is an outstanding contributor to the development of BioTek’s scientific expertise, especially in preclinical small molecule drug discovery.”
Mr. Larson’s contributions include development of marketing collateral for global conferences such as The Society for Biomolecular Sciences, Drug Discovery & Development Week, European Laboratory Robotics Interest Group-Society for Biomolecular Sciences, MipTec, and the International Society for the Study of Xenobiotics. He has also published in journals such as Assay and Drug Development Technologies and theJournal of the Association of Laboratory Automation.
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.
